ArticleThe Journal of biological chemistry2026
Impact of salt concentration and free magnesium on human beta-cardiac myosin reveal important details about the conserved mechanochemical mechanism.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The E525K β-Myosin Mutation Causes Hypocontractility in Cardiomyocytes Without Altering Loaded Crossbridge Cycling.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The myosin ATPase cycle is dramatically accelerated by the presence of actin, while the structural details of actin-activation are still unclear. We found that a dilated cardiomyopathy mutation, E525K, in human beta-cardiac myosin subfragment 1 (S1) enhanced actin-activation of phosphate release and lever arm rotation ∼3-fold. We hypothesized that abolishment of the conserved 484 to 525 salt bridge allows for lysine 525 to more readily interact with actin. Indeed, we found that actin-activated ATPase activity of E525K was quite resistant to changes in salt concentration (20 mM to 100 mM KCl) compared to the WT motor, while in vitro actin-gliding velocities were similarly altered. Direct measurements of pyrene actin binding revealed that the E525K mutation accelerates attachment to actin. We found that the actin-activated ATPase activity of E525K was less sensitive to magnesium (Mg) than WT, indicating that the mutation allosterically alters the coordination of Mg in the active site. In addition, the Mg dependence of ADP release was significantly faster in the mutant at low Mg. Molecular dynamics simulations demonstrate that E525K increases the conformational variation of the active site in the ADP-bound state. Our results suggest that the E525K mutation enhances actin affinity by accelerating the transition from weak to strong actin binding, which highlights the importance of the activation loop/relay helix communication pathway during actin-activated Pi-release. In addition, E525K alters Mg coordination in the active site further demonstrating the importance of the 484 to 525 salt bridge in allosterically coupling the active site and actin-binding region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.